BeyondSpring Inc
For the period ended Dec 31, 2023. Filed Apr 29, 2024.
View on SEC.govAbout this filing
The yearly report of a company based outside the US. It covers much of what a 10-K does, and may follow accounting rules other than US ones.
FY2023 · Filed Apr 29, 2024
BYSI$0.63-1.0%Stored close · as of Nov 6, 2026
Contents
Item 16B. Code of Ethics
In connection with our initial public offering, we have adopted a written code of ethics that applies to all of our directors, executive officers and employees. The code of ethics is available in the investors section of our website (www.beyondspringpharma.com/corporate-governance).
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.